fda remove semaglutide from shortage list is on the As of February 21, 2025, updated its drug list GLP-1 No Longer on FDA's

Quick Specs Form: Lyophilized powder (white to off-white) Purity: 99% by HPLC every batch Identity: MS molecular-weight confirmed every batch (critical for this compound) CAS Number: 2883634-40-8 Also Known As: LY3841136, LY-3841136, "Elora" Class: Selective amylin receptor agonist (AMY1R-selective) Sequence Length: 37-amino-acid main chain (C-terminally amidated) Molecular Formula: Not yet publicly disclosed confirm per COA / MS Molecular Weight: Not yet publicly disclosed confirm per batch MS Modification: Cys2Cys7 methylene thioacetal bridge

It belongs to a newer class of drugs sometimes called incretin or multi-agonist peptide therapies the same broad family as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)

These follow-ups are essential to ensure that the treatment is effective and to manage any side effects

Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study

The first amylin-analog, pramlintide, was approved for the treatment of diabetes in 2005